Academic Respiratory Unit, Learning and Research Building, Southmead Hospital, Bristol, UK.
Bristol Renal, Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
Respir Res. 2018 Jan 15;19(1):9. doi: 10.1186/s12931-017-0711-x.
Dysregulation of VEGF-A bioavailability has been implicated in the development of lung injury/fibrosis, exemplified by Idiopathic Pulmonary Fibrosis (IPF). VEGF-A is a target of the hypoxic response via its translational regulation by HIF-1α. The role of hypoxia and hyperoxia in the development and progression of IPF has not been explored. In normal lung (NF) and IPF-derived fibroblasts (FF) VEGF-Aa protein expression was upregulated by hypoxia, mediated through activation of VEGF-Aa gene transcription. VEGF-A receptors and co-receptors were differentially expressed by hypoxia and hyperoxia. Our data supports a potential role for hypoxia, hyperoxia and VEGF-Aa isoforms as drivers of fibrogenesis.
血管内皮生长因子-A(VEGF-A)生物利用度的失调与肺损伤/纤维化的发生有关,特发性肺纤维化(IPF)就是一个例子。VEGF-A 通过其翻译调节因子缺氧诱导因子-1α(HIF-1α)受到缺氧的调控。缺氧和高氧在 IPF 的发生和进展中的作用尚未被探索。在正常肺(NF)和 IPF 衍生的成纤维细胞(FF)中,VEGF-Aa 蛋白表达被低氧上调,这是通过 VEGF-Aa 基因转录的激活介导的。VEGF-A 受体和共受体通过缺氧和高氧表现出不同的表达。我们的数据支持缺氧、高氧和 VEGF-Aa 异构体作为纤维化驱动因素的潜在作用。